{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:41:02Z","timestamp":1792600862427,"version":"4.5.0"},"reference-count":34,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_med-2026-1531_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Sarcopenia is common among individuals with impaired kidney function and is associated with poor quality of life and adverse clinical outcomes. This study aimed to investigate the association between sarcopenia and all-cause mortality among Chinese community-dwelling middle-aged and older adults with an estimated glomerular filtration rate (eGFR) of 15\u201389\u202fmL\/min\/1.73\u202fm\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1531_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using data from the China Health and Retirement Longitudinal Study (CHARLS), we included 2,526 participants aged 45\u201385\u202fyears with an eGFR of 15\u201389\u202fmL\/min\/1.73\u202fm\n                      <jats:sup>2<\/jats:sup>\n                      who were followed from 2011 to 2018. Because albuminuria and other markers of kidney damage were unavailable, the study population was operationally defined according to eGFR criteria. Cox proportional hazards regression models were used to evaluate the association between sarcopenia and all-cause mortality. Exploratory analyses assessed the incremental prognostic value of sarcopenia using 5-year time-dependent area under the receiver operating characteristic curve (AUC), integrated discrimination improvement (IDI), and continuous net reclassification improvement (NRI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1531_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 2,526 participants included in the final analysis, the prevalence of sarcopenia was 28.1\u202f% (335\/1,194) in men and 41.4\u202f% (551\/1,332) in women. After adjustment for potential confounders, sarcopenia was associated with a significantly higher risk of all-cause mortality in women (HR, 1.82; 95\u202f% CI, 1.26\u20132.63). In exploratory analyses, the addition of sarcopenia to the clinical variable-based model modestly improved 5-year mortality risk discrimination in women, increasing the time-dependent AUC from 0.615 (95\u202f% CI, 0.561\u20130.670) to 0.650 (95\u202f% CI, 0.599\u20130.700). The IDI was 0.008 (95\u202f% CI, 0.003\u20130.014; p=0.006), whereas the continuous NRI was 0.236 (95\u202f% CI,\u00a0\u22120.055\u20130.417; p=0.090).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1531_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Sarcopenia was associated with an increased risk of all-cause mortality among women with an eGFR of 15\u201389\u202fmL\/min\/1.73\u202fm\n                      <jats:sup>2<\/jats:sup>\n                      . Sarcopenia may provide additional prognostic information beyond conventional clinical risk factors, although the incremental prognostic findings were exploratory and require further validation. The clinical utility of sarcopenia assessment for mortality risk stratification remains to be established.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2026-1531","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:56:31Z","timestamp":1792598191000},"source":"Crossref","is-referenced-by-count":0,"title":["The role of sarcopenia in all-cause mortality prediction among community-dwelling adults with eGFR 15\u201389\u202fmL\/min\/1.73\u202fm\n                    <sup>2<\/sup>"],"prefix":"10.1515","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-1897","authenticated-orcid":false,"given":"Kaili","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Nephrology , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4372-2180","authenticated-orcid":false,"given":"Bowen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nephrology , Zhongshan Hospital, Fudan University , Shanghai , China"},{"name":"Shanghai Medical Center of Kidney Disease , Shanghai , China"},{"name":"Shanghai Key Laboratory of Kidney and Blood Purification , Shanghai , China"},{"name":"Shanghai Institute of Kidney and Dialysis , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Nephrology , Zhongshan Hospital, Fudan University , Shanghai , China"},{"name":"Shanghai Medical Center of Kidney Disease , Shanghai , China"},{"name":"Shanghai Key Laboratory of Kidney and Blood Purification , Shanghai , China"},{"name":"Shanghai Institute of Kidney and Dialysis , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5890-8087","authenticated-orcid":false,"given":"Yan","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Nephrology , Zhongshan Hospital, Fudan University , Shanghai , China"},{"name":"Shanghai Medical Center of Kidney Disease , Shanghai , China"},{"name":"Shanghai Key Laboratory of Kidney and Blood Purification , Shanghai , China"},{"name":"Shanghai Institute of Kidney and Dialysis , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102115562514122_j_med-2026-1531_ref_001","doi-asserted-by":"crossref","unstructured":"Satake, S, Arai, H. Chapter 1 frailty: definition, diagnosis, epidemiology. Geriatr Gerontol Int 2020;20:7\u201313. https:\/\/doi.org\/10.1111\/ggi.13830.","DOI":"10.1111\/ggi.13830"},{"key":"2026102115562514122_j_med-2026-1531_ref_002","doi-asserted-by":"crossref","unstructured":"Damluji, AA, Alfaraidhy, M, AlHajri, N, Rohant, NN, Kumar, M, Al Malouf, C, et al.. Sarcopenia and cardiovascular diseases. Circulation 2023;147:1534\u201353. https:\/\/doi.org\/10.1161\/circulationaha.123.064071.","DOI":"10.1161\/CIRCULATIONAHA.123.064071"},{"key":"2026102115562514122_j_med-2026-1531_ref_003","doi-asserted-by":"crossref","unstructured":"Fang, P, Zhou, J, Xiao, X, Yang, Y, Luan, S, Liang, Z, et al.. The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J\u00a0Cachexia Sarcopenia Muscle 2022;14:3\u201316. https:\/\/doi.org\/10.1002\/jcsm.13126.","DOI":"10.1002\/jcsm.13126"},{"key":"2026102115562514122_j_med-2026-1531_ref_004","doi-asserted-by":"crossref","unstructured":"Zhang, F-M, Song, C-H, Guo, Z-Q, Yu, Z, Weng, M, Zhou, F-X, et al.. Sarcopenia prevalence in patients with cancer and association with adverse prognosis: a nationwide survey on common cancers. Nutrition 2023;114:112107. https:\/\/doi.org\/10.1016\/j.nut.2023.112107.","DOI":"10.1016\/j.nut.2023.112107"},{"key":"2026102115562514122_j_med-2026-1531_ref_005","doi-asserted-by":"crossref","unstructured":"Esteban-Cornejo, I, Ho, FK, Petermann-Rocha, F, Lyall, DM, Martinez-Gomez, D, Cabanas-S\u00e1nchez, V, et al.. Handgrip strength and all-cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study. J\u00a0Cachexia Sarcopenia Muscle 2022;13:1514\u201325. https:\/\/doi.org\/10.1002\/jcsm.12857.","DOI":"10.1002\/jcsm.12857"},{"key":"2026102115562514122_j_med-2026-1531_ref_006","doi-asserted-by":"crossref","unstructured":"Moorthi, RN, Avin, KG. Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens 2017;26:219\u201328. https:\/\/doi.org\/10.1097\/mnh.0000000000000318.","DOI":"10.1097\/MNH.0000000000000318"},{"key":"2026102115562514122_j_med-2026-1531_ref_007","doi-asserted-by":"crossref","unstructured":"Navaneethan, SD, Schold, JD, Arrigain, S, Jolly, SE, Nally, JV. Cause-specific deaths in non-dialysis-dependent CKD. J\u00a0Am Soc Nephrol : JASN (J Am Soc Nephrol) 2015;26:2512\u201320. https:\/\/doi.org\/10.1681\/asn.2014101034.","DOI":"10.1681\/ASN.2014101034"},{"key":"2026102115562514122_j_med-2026-1531_ref_008","doi-asserted-by":"crossref","unstructured":"Cruz-Jentoft, AJ, Sayer, AA. Sarcopenia. Lancet (London, England) 2019;393:2636\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(19)31138-9.","DOI":"10.1016\/S0140-6736(19)31138-9"},{"key":"2026102115562514122_j_med-2026-1531_ref_009","doi-asserted-by":"crossref","unstructured":"Chatzipetrou, V, B\u00e9gin, M-J, Hars, M, Trombetti, A. Sarcopenia in chronic kidney disease: a scoping review of prevalence, risk factors, association with outcomes, and treatment. Calcif Tissue Int 2022;110:1\u201331. https:\/\/doi.org\/10.1007\/s00223-021-00898-1.","DOI":"10.1007\/s00223-021-00898-1"},{"key":"2026102115562514122_j_med-2026-1531_ref_010","doi-asserted-by":"crossref","unstructured":"Chen, Z, Li, W-Y, Ho, M, Chau, P-H. The prevalence of sarcopenia in Chinese older adults: meta-analysis and meta-regression. Nutrients 2021;13:1441. https:\/\/doi.org\/10.3390\/nu13051441.","DOI":"10.3390\/nu13051441"},{"key":"2026102115562514122_j_med-2026-1531_ref_011","doi-asserted-by":"crossref","unstructured":"Kitamura, A, Seino, S, Abe, T, Nofuji, Y, Yokoyama, Y, Amano, H, et al.. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J\u00a0Cachexia Sarcopenia Muscle 2020;12:30\u20138. https:\/\/doi.org\/10.1002\/jcsm.12651.","DOI":"10.1002\/jcsm.12651"},{"key":"2026102115562514122_j_med-2026-1531_ref_012","doi-asserted-by":"crossref","unstructured":"Tantai, X, Liu, Y, Yeo, YH, Praktiknjo, M, Mauro, E, Hamaguchi, Y, et al.. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J\u00a0Hepatol 2021;76:588\u201399. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.006.","DOI":"10.1016\/j.jhep.2021.11.006"},{"key":"2026102115562514122_j_med-2026-1531_ref_013","doi-asserted-by":"crossref","unstructured":"Shen, Y, Qin, H, Liu, X, Liu, L, Chen, S, Yang, Y, et al.. Calf circumference predicts sarcopenia and all-cause mortality in older patients undergoing maintenance hemodialysis: a prospective cohort study. Nutr Clin Pract 2026;41:235\u201344. https:\/\/doi.org\/10.1002\/ncp.11337.","DOI":"10.1002\/ncp.11337"},{"key":"2026102115562514122_j_med-2026-1531_ref_014","doi-asserted-by":"crossref","unstructured":"Kim, D, Wijarnpreecha, K, Sandhu, KK, Cholankeril, G, Ahmed, A. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United\u00a0States. Liver international. Off J Int Assoc Study Liver 2021;41:1832\u201340. https:\/\/doi.org\/10.1111\/liv.14852.","DOI":"10.1111\/liv.14852"},{"key":"2026102115562514122_j_med-2026-1531_ref_015","doi-asserted-by":"crossref","unstructured":"Henriksson, H, Henriksson, P, Tynelius, P, Ortega, FB. Muscular weakness in adolescence is associated with disability 30\u00a0years later: a population-based cohort study of 1.2 million men. Br J Sports Med 2019;53:1221\u201330. https:\/\/doi.org\/10.1136\/bjsports-2017-098723.","DOI":"10.1136\/bjsports-2017-098723"},{"key":"2026102115562514122_j_med-2026-1531_ref_016","doi-asserted-by":"crossref","unstructured":"Zhao, Y, Hu, Y, Smith, JP, Strauss, J, Yang, G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol 2012;43:61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","DOI":"10.1093\/ije\/dys203"},{"key":"2026102115562514122_j_med-2026-1531_ref_017","doi-asserted-by":"crossref","unstructured":"Chen, L-K, Woo, J, Assantachai, P, Auyeung, T-W, Chou, M-Y, Iijima, K, et al.. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J\u00a0Am Med Dir Assoc 2020;21:300\u20137.e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012.","DOI":"10.1016\/j.jamda.2019.12.012"},{"key":"2026102115562514122_j_med-2026-1531_ref_018","doi-asserted-by":"crossref","unstructured":"Yang, M, Hu, X, Wang, H, Zhang, L, Hao, Q, Dong, B. Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study. J\u00a0Cachexia Sarcopenia Muscle 2016;8:251\u20138. https:\/\/doi.org\/10.1002\/jcsm.12163.","DOI":"10.1002\/jcsm.12163"},{"key":"2026102115562514122_j_med-2026-1531_ref_019","unstructured":"Liu, L-S 2010 Chinese guidelines for the management of hypertension. Zhonghua Xinxueguanbing Zazhi 2011;39:579\u2013615."},{"key":"2026102115562514122_j_med-2026-1531_ref_020","doi-asserted-by":"crossref","unstructured":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2024. Diabetes Care 2024;47:S20\u201342.","DOI":"10.2337\/dc24-S002"},{"key":"2026102115562514122_j_med-2026-1531_ref_021","doi-asserted-by":"crossref","unstructured":"Dahl, H, Rosendahl-Riise, H, Marti, H-P, Dierkes, J. The association of sarcopenia and central obesity with mortality risk in patients with chronic kidney disease\u00a0\u2013\u00a0a 2-year observational study. Curr Dev Nutr 2023;7:100014. https:\/\/doi.org\/10.1016\/j.cdnut.2022.100014.","DOI":"10.1016\/j.cdnut.2022.100014"},{"key":"2026102115562514122_j_med-2026-1531_ref_022","doi-asserted-by":"crossref","unstructured":"Kittiskulnam, P, Chertow, GM, Carrero, JJ, Delgado, C, Kaysen, GA, Johansen, KL. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int 2017;92:238\u201347. https:\/\/doi.org\/10.1016\/j.kint.2017.01.024.","DOI":"10.1016\/j.kint.2017.01.024"},{"key":"2026102115562514122_j_med-2026-1531_ref_023","doi-asserted-by":"crossref","unstructured":"Wang, L, Zhu, B, Xue, C, Zhou, F, Luo, Q. Sarcopenia is associated with mortality among newly initiated peritoneal dialysis patients with end-stage kidney disease: a longitudinal follow-up study. BMC Nephrol 2025;27:17. https:\/\/doi.org\/10.1186\/s12882-025-04664-5.","DOI":"10.1186\/s12882-025-04664-5"},{"key":"2026102115562514122_j_med-2026-1531_ref_024","doi-asserted-by":"crossref","unstructured":"Ye, L, Liang, R, Liu, X, Li, J, Yue, J, Zhang, X. Frailty and sarcopenia: a bibliometric analysis of their association and potential targets for intervention. Ageing Res Rev 2023;92:102111. https:\/\/doi.org\/10.1016\/j.arr.2023.102111.","DOI":"10.1016\/j.arr.2023.102111"},{"key":"2026102115562514122_j_med-2026-1531_ref_025","doi-asserted-by":"crossref","unstructured":"Hyde, Z, Flicker, L, Almeida, OP, Hankey, GJ, McCaul, KA, Chubb, SAP, et al.. Low free testosterone predicts frailty in older men: the health in men study. J\u00a0Clin Endocrinol Metabol 2010;95:3165\u201372. https:\/\/doi.org\/10.1210\/jc.2009-2754.","DOI":"10.1210\/jc.2009-2754"},{"key":"2026102115562514122_j_med-2026-1531_ref_026","doi-asserted-by":"crossref","unstructured":"Cruz-Jentoft, AJ, Bahat, G, Bauer, J, Boirie, Y, Bruy\u00e8re, O, Cederholm, T, et al.. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afz046.","DOI":"10.1093\/ageing\/afz046"},{"key":"2026102115562514122_j_med-2026-1531_ref_027","doi-asserted-by":"crossref","unstructured":"Larsson, L, Degens, H, Li, M, Salviati, L, Lee, YI, Thompson, W, et al.. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev 2019;99:427\u2013511. https:\/\/doi.org\/10.1152\/physrev.00061.2017.","DOI":"10.1152\/physrev.00061.2017"},{"key":"2026102115562514122_j_med-2026-1531_ref_028","doi-asserted-by":"crossref","unstructured":"Westbury, LD, Beaudart, C, Bruy\u00e8re, O, Cauley, JA, Cawthon, P, Cruz-Jentoft, AJ, et al.. Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: findings from population-based cohorts. J\u00a0Cachexia Sarcopenia Muscle 2023;14:565\u201375. https:\/\/doi.org\/10.1002\/jcsm.13160.","DOI":"10.1002\/jcsm.13160"},{"key":"2026102115562514122_j_med-2026-1531_ref_029","doi-asserted-by":"crossref","unstructured":"He, J, Huang, M, Li, N, Zha, L, Yuan, J. Genetic association and potential mediators between sarcopenia and coronary heart disease: a bidirectional two-sample, two-step Mendelian randomization study. Nutrients 2023;15:3013. https:\/\/doi.org\/10.3390\/nu15133013.","DOI":"10.3390\/nu15133013"},{"key":"2026102115562514122_j_med-2026-1531_ref_030","doi-asserted-by":"crossref","unstructured":"Dajti, E, Renzulli, M, Ravaioli, F, Marasco, G, Vara, G, Brandi, N, et al.. The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis. Dig Liver Dis 2023;55:637\u201343. https:\/\/doi.org\/10.1016\/j.dld.2022.11.011.","DOI":"10.1016\/j.dld.2022.11.011"},{"key":"2026102115562514122_j_med-2026-1531_ref_031","doi-asserted-by":"crossref","unstructured":"Maniscalco, L, Veronese, N, Ragusa, FS, Vernuccio, L, Dominguez, LJ, Smith, L, et al.. Sarcopenia using muscle mass prediction model and\u00a0cognitive impairment: a longitudinal analysis from the English longitudinal study on ageing. Arch Gerontol Geriatr 2024;117:105160. https:\/\/doi.org\/10.1016\/j.archger.2023.105160.","DOI":"10.1016\/j.archger.2023.105160"},{"key":"2026102115562514122_j_med-2026-1531_ref_032","doi-asserted-by":"crossref","unstructured":"Cesari, M, Kritchevsky, SB, Newman, AB, Simonsick, EM, Harris, TB, Penninx, BW, et al.. Added value of physical performance measures in\u00a0predicting adverse health-related events: results from the health,\u00a0aging and body composition study. J\u00a0Am Geriatr Soc 2009;57:251\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.02126.x.","DOI":"10.1111\/j.1532-5415.2008.02126.x"},{"key":"2026102115562514122_j_med-2026-1531_ref_033","doi-asserted-by":"crossref","unstructured":"Guralnik, JM, Simonsick, EM, Ferrucci, L, Glynn, RJ, Berkman, LF, Blazer, DG, et al.. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J\u00a0Gerontol 1994;49:M85\u201394. https:\/\/doi.org\/10.1093\/geronj\/49.2.m85.","DOI":"10.1093\/geronj\/49.2.M85"},{"key":"2026102115562514122_j_med-2026-1531_ref_034","doi-asserted-by":"crossref","unstructured":"Studenski, S, Perera, S, Patel, K, Rosano, C, Faulkner, K, Inzitari, M, et al.. Gait speed and survival in older adults. JAMA 2011;305:50\u20138.","DOI":"10.1001\/jama.2010.1923"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1531\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1531\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:56:36Z","timestamp":1792598196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1531\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,10,22]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/med-2026-1531"],"URL":"https:\/\/doi.org\/10.1515\/med-2026-1531","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20261531"}}